Similarly, voltage-gated sodium channel β3 subunit (SCN3B) has been identified as a prognostic biomarker for gliomas, specifically oligodendroglioma [6], where higher levels of SCN3B correlate with longer survival. This evidence concerns the gene SCN3B and central nervous system cancer.